Keros Therapeutics, Inc. (KROS) Form 10-Q Quarterly Reports
Keros Therapeutics, Inc. (KROS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KROS
CIK: 1664710
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerMichelle Marseglia
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-29 | 8-K | 0001664710-26-000059 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-28 | 8-K | 0001664710-26-000056 | View SEC Doc Filr Page |
| EFFECT | 2026-09-16 | — | EFFECT Filing | 9999999995-26-002985 | View SEC Doc Filr Page |
| DEL AM | 2026-09-11 | — | DEL AM | 0001628280-26-061536 | View SEC Doc Filr Page |
| S-3 | 2026-09-10 | — | S-3 | 0001628280-26-061321 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001664710-26-000053 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 Filing | 0002146784-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 Filing | 0002081359-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 Filing | 0002081460-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 Filing | 0001866219-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001221590-26-000025 | View SEC Doc Filr Page |
| 144 | 2026-08-18 | — | 144 Filing | 0001969223-26-000924 | View SEC Doc Filr Page |
| 3 | 2026-08-13 | 2026-08-04 | 3 Filing | 0002146784-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001664710-26-000050 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001664710-26-000049 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001664710-26-000048 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001664710-26-000043 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0002012383-26-002890 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-17 | 8-K | 0001664710-26-000038 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 Filing | 0001221590-26-000023 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-17 | — | SCHEDULE 13G Filing | 0002052113-26-000752 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 Filing | 0001797917-26-000007 | View SEC Doc Filr Page |
| 3 | 2026-07-06 | 2026-07-01 | 3 Filing | 0001797917-26-000005 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-23 | 8-K | 0001664710-26-000036 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | 4 Filing | 0001221590-26-000021 | View SEC Doc Filr Page |